dial medullary lamina in the pallidum at the level of the AC-PC, was significantly associated with improved tics but not mood or OCB outcome. Conclusions: This study adds further support to the application of DBS in a tic-related network, though factors such as patient sample size and clinical heterogeneity remain as limitations and replication is required.
Introduction
Deep brain stimulation (DBS) for Tourette syndrome (TS) is emerging as a safe and efficacious treatment option for patients with severe treatment-refractory tics. Out of 9 targets within the brain hitherto chosen for DBS, the medial thalamus and globus pallidus internus (GPi) regions have been the sites most consistently reported to lead to long-term beneficial effects. Nonetheless, identification of the optimal target for chronic stimulation within a tic-related cortical-subcortical basal ganglia-thalamic network is yet to be elucidated.
The anteromedial or limbic GPi (amGPi) has yielded promising results as a DBS target for TS patients not only in a number of open label case series [1] [2] [3] [4] [5] , but also in a recent randomised controlled trial [6] . However, even among patients receiving bilateral amGPi DBS, there is considerable variability in response raising uncertainty regarding the optimal site for electrode placement even within this region.
A potential approach to aid the identification of the optimal target within the limbic GPi in TS patients is by comparison of the variation in clinical outcomes to patient-specific electric field (EF) simulations. The latter involves outlining the extent of current spread around the exact imaged location of DBS electrodes, taking into account stimulation parameters and individual anatomical variation, thus enabling mapping of the anatomical brain regions stimulated by DBS [7] . Proof of concept of this approach has been previously demonstrated in a study that used the finite-element method to map the current distribution in 5 TS patients targeted at the GPi [8] . The comparison of this type of EF simulation to the long-term tic and comorbidity improvement in larger numbers of patients should help elucidate the optimal anatomical target for electrode placement and a similar approach has been taken in patients with Parkinson disease [9] . Our study therefore attempts to further address the feasibility of this approach by applying it in 15 patients with severe, refractory TS who have had long-term follow-up after bilateral amGPi DBS.
Methods

Clinical Data
The patients recruited to this study remain under follow-up at the National Hospital of Neurology and Neurosurgery, London, UK, and had all received bilateral DBS to the amGPi region for severe treatment-refractory TS. Only patients with both pre-and postoperative MR images and clinical data from long-term followup (>12 months) were included.
All patients were resistant to at least 3 different types of pharmacological therapies, including dopamine-blocking agents. Specific inclusion criteria included a diagnosis of stable severe refractory TS, a Yale Global Tic Severity Scale (YGTSS) score of greater than 35/55 for at least 12 months, lack of response to 3 different classes of conventional medical treatment at therapeutic doses, unsuccessful or unstable behavioural therapy outcome, comorbid symptoms optimally treated for at least 6 months, as well as compliance with surgical treatment plans or psychosocial interventions. Exclusion criteria comprised a tic disorder attributed to another cause, the presence of medical or psychiatric disorders that may increase the risk of procedure, or psychosocial factors impacting on postoperative care and research participation.
Our surgical procedure has been previously described [10] . The process for selecting the target within the amGPi was consistent across the course of the study. The target within the amGPi was determined by direct visual inspection using a stereotactic thinslice proton density MRI sequence to directly visualise the pallidal anatomy [11] . For the targeting, we used commercially available planning software (Framelink, Medtronic, Minneapolis, MN, USA). On an axial slice at the level of the AC-PC line, the GPi can be divided into an anterior, middle, and posterior third. The electrode was targeted to the centre of the anterior third of the GPi.
The entry point was defined at or behind the coronal suture and at a laterality such as to ensure a trajectory that would avoid sulci and the ventricular system, while maintaining an orthogonal approach towards the GPi. The exact entry and target point were subsequently modified to maintain a parenchymal trajectory whilst maximising the length of the trajectory within the visible amGPi. An immediate postoperative stereotactic MRI with the frame still on the head verified the DBS electrode location in the anteromedial GPi. All patients received Activa PC implantable pulse generators (Medtronic, Minneapolis, MN, USA).
Clinical assessments were performed pre-and postoperatively with validated scoring systems consisting of the YGTSS [12] and the Modified Rush Video Rating Scale (MRVRS) [13] to measure tic frequency and severity, the Gilles de la Tourette Quality of Life Scale (GTS-QOL) [14] , the Yale Brown Obsessive Compulsive Scale (Y-BOCS) for OCB outcome [15] , the Beck Depression Inventory (BDI), and the State Trait Anxiety Inventory (STAI). A 2-tailed t test was used to compare baseline and latest follow-up scores using SPSS version 22. The percentage difference between baseline and latest follow-up scores were calculated (baseline -latest follow-up/baseline) for each parameter. These percentage changes were then used in the subsequently described linear modelling analysis.
Creation of EFs for Patient-Specific Modelling
The optimal DBS parameters including frequency, voltage, pulse width, and the number of active contacts were recorded for each patient.
Brain Model
Pre-implantation axial MR images were coregistered with immediate postimplantation axial MR images using an open source software (3DSlicer; www.slicer.org) and the x , y , and z co-ordinates for contacts were obtained for each patient. The co-ordinates for the active stimulation contacts were subsequently used in the brain and electrode model to outline the fields of stimulation.
A software tool developed in Matlab 2015a (MathWorks, USA) named ELMA [8, 16] was used to assign the electric conductivities, σ (S/m), in the models based on the voxel intensities in the T1 preimplantation MR image sets. Images were exported as .nrrd files for reading into Matlab. Average intensities for grey matter, white matter, and cerebrospinal fluid were calculated in regions of interest around the DBS target and were used to classify the voxels into these tissue types. For voxels with intensities within the middle third of the averages for 2 tissue types, the conductivity values were linearly interpolated with intensity between the conductivity values for the 2 tissue types. The (mainly pulse width-dependent) electric conductivities of the tissue types were calculated by the weighted average between 10 and 10 6 Hz of the Fourier transform of the DBS pulse shape [17] with conductivity spectra taken from a compilation by Gabriel et al. [18, 19] . The conductivity matrix was saved for a cuboid corresponding to the dimensions of each brain.
Electrode Model
The DBS electrodes (DBS lead model 3389; Medtronic Inc., USA) with a radius of 0.635 mm, a contact length of 1.5 mm, and 
Boundary Conditions
For each patient, the active contacts were set to the corresponding electric potential, V (V) while the surrounding of the brain model was set to ground ( V = 0 V). The plastic parts of the lead were set to electric insulation:
where n is the normal vector of the electrode contact surface S . The inactive contacts were set to floating potential:
In case of interleaved stimulation, 2 separate simulations were made for the 2 contact sets.
Governing Equation and Simulations
The equation for steady currents was solved for the brain domain around the electrodes:
using a mesh of approximately 500,000 elements and the Conjugate Gradient solver in the Cuthill McKee algorithm. From the solution, the EF isolevels estimated to trigger axons with a diameter of 2 and 5 μm, respectively, were calculated and exported as a logic matrix with the same co-ordinates as the preoperative MRI set. The required isolevels were estimated based on the pulse width used for the stimulation. Based on neuron model simulations by Åström et al. [20] , rheobase and chronaxie were calculated to be 0.041 V/mm and 99.8 μs for 5-μm axons and 0.174 V/mm and 101.4 μs for 2-μm axons. The corresponding activation levels are given in Table 1 . For interleaved stimulation, the activated volume was assumed to be the union of the activated voxels in the 2 simulations ( Table 1 ) . Each patient's specific simulated EF or volume of tissue activated (VTA) within the whole brain T1 image was exported in neuroimaging informatics technology initiative (nifti) format.
Coregistration of Nifti Files to MNI Space
In order to carry out the voxel-based analysis, all patients' scans were coregistered to a standard space. Pre-implantation T1 (MPRAGE) MR scans were brain extracted using BET (Brain Extraction Tool, FSL v.5.0), which deletes non-brain tissue from a whole head MRI [21] . Native scans were coregistered to the MNI 152 standard-space T1-weighted average structural template image (1-mm resolution) [22] . This was achieved by employing linear (affine) transformation first using FLIRT (FMRIB's Linear Image Registration Tool) with 12 degrees of freedom, correlation ratio cost function, and normal search [23, 24] . The output from this step was then used to execute non-linear registration using FNIRT [25] . This process produced individual native to standard (MNI space) non-linear warp fields which were then applied to the DBS tissue activation volumetric meshes acquired in order to transform all volumes to standard space. Group averages were then generated using Fslmaths .
Linear Regression of Voxels versus Clinical Outcomes
Left-and right-sided VTAs (in MNI space) corresponding to the 2 μm axon stimulation fields were combined using Fslmerge (FSL v.5.0) into two 4D data files (1 for each hemisphere). In each voxel, each of the VTAs was modelled as a linear combination of outcome scores within the group. A simple design contrast file was used to test the significant voxels predictive of improvement in each clinical outcome variable individually.
Non-parametric permutation inference was then carried out on each voxel using Randomise (FSL v.5.0) with 5,000 permutations to build up the null distribution to test against. General linear model variables were demeaned and a single-group t test with threshold-free cluster enhancement was used as the test statistic [26] . Raw t -stat images were thresholded at α = 0.05.
Results
Clinical Outcomes
Fifteen patients were included in this study. All patients had undergone bilateral DBS surgery between 2009 and 2014. The follow-up period ranged from 17 to 82 months. There were 12 males and 3 females who had a mean age of TS onset of 7 years (range 2-12) with an average age at surgery of 32 years (range 18-49). The mean YGTSS score at baseline was 88 (range 71-98), which improved to a mean value of 54 (range 15-97) at the latest follow-up. The mean reduction in YGTSS was 38.2% (95% CI 23.6-52.8), with a percentage reduction in vocal tics of 38.2% (95% CI 23.7-52.7) and in motor tics of 33.2% (95% CI 20.3-46.0). The mean change in MRVRS observed was 40.5% (95% CI 22-59) and unobserved was 34.1% (95% CI 19.8-48.3), which correlated well with the changes in YGTSS. There was a statistically significant difference in YGTSS, including both vocal and motor tic outcome, MRVRS, quality of life outcome, as well as the comorbidities of anxiety and depression. However, despite an overall improvement in OCB outcome, statistical significance was not reached. Further subgroup analysis revealed that 4 patients with the most severe baseline OCB (score 24-31) showed a 38.7% (7.4- ( Table 2 ) .
Stimulation-related non-serious adverse effects at last follow-up reported by individual patients included weight gain, dizziness, and feelings of nausea. Other effects included freezing of gait episodes with prolonged stimulation of more ventral pallidal contacts, difficulties with speech articulation, and akathisia. In the majority of patients, adverse effects could be controlled by altering stimulation parameters. Most patients remained on presurgery medications, which mostly served to address comorbid symptoms such as depression, anxiety, and OCB.
In several patients, tolerance to the DBS developed over time, necessitating progressive increases in stimulation parameters to maintain symptom control. Table 3 confirms that 12 of our patients progressed to needing double monopolar (or in 1 case even triple monopolar) stimulation over long-term follow-up. In 7 of these patients, increases in stimulation over time were required because of a relapse in tic control which led to restoration, whereas in 5 patients progressive increases have been pursued to try and make additional improvements upon suboptimal tic control. Owing to a low tolerance of increased parameter settings, 2 patients did not derive maximum benefit, resulting in poorer tic control, and 1 patient switched off their DBS owing to little improvement. The evolution towards such high parameters has led to the need for repeated battery replacements and the switch to using rechargeable devices in increasing numbers of patients.
Modelling of Stimulation Fields in Patients
An example of the simulated stimulation fields for 1 of the 15 patients is illustrated in Figure 1 . In every patient, the active contact(s) lay within the amGPi or on the lamina between amGPi and anteromedial globus pallidum externus (amGPe). The simulations indicate that 2-μm axons exposed to stimulation lie predominantly in the GPi/GPe, whereas 5-μm axons lying medially in the internal capsule and laterally as far as the putamen are also exposed to the effects of chronic stimulation ( Fig. 1 ) .
Linear Regression Comparing Voxels Activated versus Clinical Outcome
General linear modelling revealed that the voxels activated by DBS that were most significantly predictive of improvement in motor tics, vocal tics, and YGTSS were located in the ventral limbic GPi. Specifically, there were 3 convergent clusters on the medial medullary lamina in the pallidum at the level of the AC-PC. The areas of maximum efficacy for these 3 outcomes along with the average VTA are shown in Figure 2 . We did not find any voxels significantly associated with percentage improvement in any of the other clinical outcome measures. None of the significant clusters of voxels survived correction for multiple comparisons ( Fig. 2 ) .
Discussion
The long-term outcome data presented here demonstrates that mean YGTSS tic improvement from baseline to latest follow-up in the 15 patients included is encouraging but responses can be highly variable. This supports the search for between-patient factors, including the site of stimulation delivery to explain the variability in response. The results of our EF simulation study demonstrate that the most consistent stimulation site associated with vocal and motor tic improvement is the anteromedial limbic GPi bordering on the lamina medullaris interna between the GPi and GPe. However, this region was not associated with improvement in mood or OCB outcome, suggesting that there may be some degree of separation between the brain networks involved in tic generation from those involved in obsessive compulsive behaviour or mood disturbance despite their frequent coexistence within patients with severe TS.
The interpretation of our results should be considered in light of potential limiting factors at various stages of the analysis, which will be considered in turn. Firstly, the accuracy of clinical data was limited by the subjectivity of rating scales such as the Y-BOCS, which can be highly variable between time points and influenced by patient insight and reporting. Although the change in OCB outcome did not reach statistical significance, subgroup analysis revealed that 4 patients with the most severe OCB symptoms had the greatest improvement, suggesting that results may differ in a larger cohort of patients with more severe baseline OCB. The YGTSS is currently the most widely accepted measure of tic severity and reflects the level of tic control during the previous week, rather than the acute snapshot of tic severity that is recorded by the MRVRS. Secondly, the creation of simulation fields, involved the use of computer simulations that assumed an isotropic electrical conductivity of tissue and the random orientation of axons. In reality, white matter in particular is anisotropic with preferential axon directions leading to both changes in the extension of the EF isolevels and the ease at which the axons are triggered. However, previous simulation studies have shown this to be only a minor influence, compared with cerebrospinal fluid-filled cysts due to Virchow Robin spaces [27] , for instance. Another parameter that is unknown is the exact distribution of axon diameters in the regions of interest; as wider diameter axons are easier to trigger, this will affect what EF isolevel is relevant for calculation of the stimulation [20] . The axon model used to calculate the triggering isolevels also contains parameters other than axon diameter that could affect the ease of activation, such as internodal length.
For these reasons, the isolevels for 2 different axon diameters are presented in this paper and were chosen from the smallest and largest simulated by Åström et al. [20] . An electron microscopy study of axon diameter by Liewald et al. [28] indicated that the median inner axon diameter in white matter axons is around 0.5 μm and the maximum inner diameter is below 5 μm in most structures. The larger outer axon diameter of 5 μm used in this study should thus be seen as the approximate upper limit, though it would have been interesting to have estimates of the required EF for activation of diameters smaller than 2 μm. Comparisons of EF levels with the borders of the GPi by Hemm et al. [29] indicates that an EF isolevel of 0.2 V/mm is the best fit for axon activation, which corresponds to an axon diameter of approximately 3.5 μm [20] . It may thus be that activation of a small subset of the largest axons is sufficient for the therapeutic effect of DBS.
Apart from intrinsic uncertainties in the electric conductivities of the different tissue types, there is also a tendency for gliosis formation around the electrode lead that somewhat reduces the electric conductivity in the closest vicinity [30] , the effect of which has not been included. Previous simulations by Yousif et al. [31] and Alonso et al. [32] , however, show that this has little impact at chronic stimulation points, as was the case in our study. Further limitations lie in MRI resolution and the contrast between different tissue types, which introduces some uncertainty in the tissue classification of the voxels and for neural tissue, as well as a dependency from axon activation on the electric conductivity [33] .
Coregistration of preoperative and postoperative images, followed by coregistration to MNI space following the field simulations is a further potential source of error. At each stage, we used whole brain data and utilised the linear and non-linear registration tools to minimise errors introduced by the coregistration process. Finally, as was demonstrated by the loss of significance after correction for multiple comparisons, the small sample size was an important limitation. Although we included 3 times more patients than the previous study assessing EF simulations in TS, it is likely that other patient-specific factors exist, such as age, symptom duration, comorbidity, and medication exposures, all of which impact on the degree of tic improvement.
In the majority of patients, tic improvement translated into functional gains. However, we observed that the symptom course over time can vary, with some patients tending to reach a response plateau while others deteriorate in comparison to previous follow-up points, unless stimulation parameters are progressively increased, although in general such patients do not decline to baseline tic severity. These observations are supported by previous long-term studies targeting the pallidum [2, 3] , though whether other factors also predict long-term tic outcome remains unclear.
Tic control is an important aspect of quality of life and tends to dominate the picture when first discussing the potential use of DBS in severely affected TS patients. However non-tic comorbidities also have a crucial impact on patient quality of life and these can become the focus of the patient's attention once tic severity decreases. While patients continue to have significant improvements in mood and quality of life following DBS, improvements in OCB do not reach the threshold for statistical significance, and in our imaging analyses changes in these other variables were not significantly related to the minor variability in the site of electrical stimulation.
We conclude that chronic high-frequency stimulation, particularly in the anterior limbic GPi, is most associated with long-term improved motor and vocal tic outcome. Although we plan to already learn from these data to inform future electrode targeting at this region, we acknowledge that the methods we have utilised require replication in a larger number of patients in order to improve reliability. We of course cannot conclude that amGPi DBS is superior to stimulation through electrode targeting in other GPi regions or the centromedian thalamus; however, our findings may help future targeting within the amGPi region. It can be argued that due to patientspecific factors, i.e., differing TS patient phenotypes, there is unlikely to be 1 target region that will benefit all patients to the same degree. Anecdotally, we have observed several patients with optimal responses from the dorsal contacts of the electrodes lying within the amGPe. This is consistent with a previous report of efficacy of GPe DBS in TS patients [34] . Therefore, collecting more information about patient comorbidities and tic types in relation to patient-specific simulations and outcomes may help to further individualise targeting.
Given the observation of tolerance emerging in some patients, the role of plasticity in tic and behaviour-related networks should also be considered. Stimulation of 1 node in a tic-related network may eventually lead to the escape of abnormal firing patterns into different networks, which could partly explain the increased tolerance that some patients with DBS can develop. Understanding network changes over time in patients with DBS for TS, for example by using functional imaging, may aid understanding of this phenomenon of tolerance and elucidate further those networks that are involved in tic expression and their anatomical connections with relevance for future electrode targeting.
